The Manufacturing Backbone: Why Blow-Fill-Seal Is Central to a Secure Sterile Supply Chain

Reliable sterile supply demands high sterility assurance with consistent, scalable output. Blow-Fill-Seal (BFS) achieves this by forming, filling and hermetically sealing containers in a single closed, automated cycle. With minimal human intervention and no glass or container preparation, BFS lowers contamination risk and simplifies packaging supply, while unit-dose formats enable preservative-free ophthalmic, respiratory and parenteral products.

This session follows BFS across the value chain.

Rommelag, the inventor of BFS and developer of the world-leading bottelpack technology, introduces the platform and the engineering principles behind it.
BioCina, a global CDMO with commercial BFS manufacturing in Perth, Australia, explains how products are developed, transferred and released on the platform.
LumaCina, which supplies an established portfolio of sterile medicines to hospitals across Australia, New Zealand and international markets, draws on decades of commercial experience to show how BFS manufacturing translates into dependable supply for patients.

Across technology, manufacturing and supply, the session reveals why BFS has become a strategic platform rather than simply a manufacturing choice, and where it can strengthen product quality, streamline production and support continuity of sterile supply.